InvestorsHub Logo
Followers 35
Posts 1393
Boards Moderated 0
Alias Born 09/09/2009

Re: Peacefulwendy post# 34166

Friday, 04/10/2015 1:59:47 PM

Friday, April 10, 2015 1:59:47 PM

Post# of 144814
This sounds like the exact same approach Dr. Von Hoff is taking with PharmaCyte's preclinical follow up study Wendy...

" Dr. Daniel Von Hoff describes a unique approach to the phase I trial that offers faster drug development. Known as “the complete phase Ib,” the design streamlines phase I by testing various drug combinations in one trial with multiple arms running in parallel. This structure creates rapid accrual rates, substantial economies of scale and significant time savings for sponsors versus the traditional sequential approach."

with Von Hoff moving fast into a follow up study with 13 groups compared to the 4 groups in the first study...which would give him much more to go to the FDA with for an IND...

looking forward to seeing the results soon...

bull
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News